Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 8Lymphoma 4Lymphoma, Extranodal NK-T-Cell 3Leukemia, Biphenotypic, Acute 2Recurrence 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

fludarabine phosphate 3Cyclophosphamide 3Antilymphocyte Serum 3Rituximab 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methylprednisolone 2Methotrexate 2Melphalan 2Busulfan 2Weights and Measures 1Vincristine 1Thioguanine 1Tacrolimus 1Ritonavir 1Prednisolone 1Polymerase Chain Reaction 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Indinavir 1Geriatric Assessment 1Gelclair 1Flow Cytometry 1Filgrastim 1Etoposide 1Dexamethasone 1Daunorubicin 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Dendritic Cell Sarcoma, Interdigitating × Asparaginase × Clear all
NCT00003423 2013-12-19

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
100 enrolled
LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡